380 related articles for article (PubMed ID: 30552025)
21. Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.
Burton S; Spicer LM; Charles TP; Gangadhara S; Reddy PBJ; Styles TM; Velu V; Kasturi SP; Legere T; Hunter E; Pulendran B; Amara R; Hraber P; Derdeyn CA
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651354
[TBL] [Abstract][Full Text] [Related]
22. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
23. Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection.
Saunders KO; Edwards RJ; Tilahun K; Manne K; Lu X; Cain DW; Wiehe K; Williams WB; Mansouri K; Hernandez GE; Sutherland L; Scearce R; Parks R; Barr M; DeMarco T; Eater CM; Eaton A; Morton G; Mildenberg B; Wang Y; Rountree RW; Tomai MA; Fox CB; Moody MA; Alam SM; Santra S; Lewis MG; Denny TN; Shaw GM; Montefiori DC; Acharya P; Haynes BF
Sci Transl Med; 2022 Sep; 14(661):eabo5598. PubMed ID: 36070369
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
25. CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques.
Sarkar S; Spencer DA; Barnette P; Pandey S; Sutton WF; Basu M; Burch RE; Cleveland JD; Rosenberg AF; Rangel-Moreno J; Keefer MC; Hessell AJ; Haigwood NL; Kobie JJ
Front Immunol; 2021; 12():757811. PubMed ID: 34745131
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.
Sanders RW; van Gils MJ; Derking R; Sok D; Ketas TJ; Burger JA; Ozorowski G; Cupo A; Simonich C; Goo L; Arendt H; Kim HJ; Lee JH; Pugach P; Williams M; Debnath G; Moldt B; van Breemen MJ; Isik G; Medina-Ramírez M; Back JW; Koff WC; Julien JP; Rakasz EG; Seaman MS; Guttman M; Lee KK; Klasse PJ; LaBranche C; Schief WR; Wilson IA; Overbaugh J; Burton DR; Ward AB; Montefiori DC; Dean H; Moore JP
Science; 2015 Jul; 349(6244):aac4223. PubMed ID: 26089353
[TBL] [Abstract][Full Text] [Related]
27. A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge.
Pegu A; Borate B; Huang Y; Pauthner MG; Hessell AJ; Julg B; Doria-Rose NA; Schmidt SD; Carpp LN; Cully MD; Chen X; Shaw GM; Barouch DH; Haigwood NL; Corey L; Burton DR; Roederer M; Gilbert PB; Mascola JR; Huang Y
Cell Host Microbe; 2019 Sep; 26(3):336-346.e3. PubMed ID: 31513771
[TBL] [Abstract][Full Text] [Related]
28. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
[TBL] [Abstract][Full Text] [Related]
29. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
[TBL] [Abstract][Full Text] [Related]
30. Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge.
Pegu A; Lovelace SE; DeMouth ME; Cully MD; Morris DJ; Li Y; Wang K; Schmidt SD; Choe M; Liu C; Chen X; Viox E; Rowshan A; Taft JD; Zhang B; Xu K; Duan H; Ou L; Todd JP; Kong R; Li H; Shaw GM; Doria-Rose NA; Kwong PD; Koup RA; Mascola JR
Sci Transl Med; 2024 Jan; 16(730):eadh9039. PubMed ID: 38232141
[TBL] [Abstract][Full Text] [Related]
31. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
32. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
33. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
Pauthner M; Havenar-Daughton C; Sok D; Nkolola JP; Bastidas R; Boopathy AV; Carnathan DG; Chandrashekar A; Cirelli KM; Cottrell CA; Eroshkin AM; Guenaga J; Kaushik K; Kulp DW; Liu J; McCoy LE; Oom AL; Ozorowski G; Post KW; Sharma SK; Steichen JM; de Taeye SW; Tokatlian T; Torrents de la Peña A; Butera ST; LaBranche CC; Montefiori DC; Silvestri G; Wilson IA; Irvine DJ; Sanders RW; Schief WR; Ward AB; Wyatt RT; Barouch DH; Crotty S; Burton DR
Immunity; 2017 Jun; 46(6):1073-1088.e6. PubMed ID: 28636956
[TBL] [Abstract][Full Text] [Related]
34. Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences.
Tartaglia LJ; Chang HW; Lee BC; Abbink P; Ng'ang'a D; Boyd M; Lavine CL; Lim SY; Sanisetty S; Whitney JB; Seaman MS; Rolland M; Tovanabutra S; Ananworanich J; Robb ML; Kim JH; Michael NL; Barouch DH
PLoS Pathog; 2016 Feb; 12(2):e1005431. PubMed ID: 26849216
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
36. Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.
Malherbe DC; Vang L; Mendy J; Barnette PT; Spencer DA; Reed J; Kareko BW; Sather DN; Pandey S; Wibmer CK; Robins H; Fuller DH; Park B; Lakhashe SK; Wilson JM; Axthelm MK; Ruprecht RM; Moore PL; Sacha JB; Hessell AJ; Alexander J; Haigwood NL
Front Immunol; 2020; 11():626464. PubMed ID: 33658998
[TBL] [Abstract][Full Text] [Related]
37. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869
[TBL] [Abstract][Full Text] [Related]
38. Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.
Bialuk I; Whitney S; Andresen V; Florese RH; Nacsa J; Cecchinato V; Valeri VW; Heraud JM; Gordon S; Parks RW; Montefiori DC; Venzon D; Demberg T; Guroff MR; Landucci G; Forthal DN; Franchini G
Vaccine; 2011 Dec; 30(1):78-94. PubMed ID: 22037204
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
40. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
